Marianne Mikaelsson

Title: The Innovative Contributions of Marianne Mikaelsson

Introduction

Marianne Mikaelsson is a notable inventor based in Bromma, Sweden. She has made significant contributions to the field of pharmaceuticals, particularly in the development of stable Factor VIII compositions. With a total of 2 patents, her work has the potential to impact the treatment of hemophilia and other related disorders.

Latest Patents

One of her latest patents focuses on stable Factor VIII compositions. This invention relates to a pharmaceutical composition that includes Factor VIII and divalent metal ions such as Zn and Cu, optionally in the presence of Ca and Mn ions. The composition is designed to remain stable without the addition of albumin. Additionally, she has developed a method for producing recombinant Factor VIII from mammalian cells, which involves culturing these cells in a medium free of plasma-derived protein and supplemented with divalent metal ions. Another patent pertains to a pharmaceutical formulation suitable for subcutaneous, intramuscular, or intradermal administration.

Career Highlights

Throughout her career, Marianne has worked with prominent companies in the pharmaceutical industry, including Pharmacia & Upjohn and Biovitrum. Her expertise in the field has allowed her to contribute to innovative solutions that address critical health issues.

Collaborations

Marianne has collaborated with several professionals in her field, including Jack Spira and Lars Widlund. These partnerships have facilitated the advancement of her research and the successful development of her patents.

Conclusion

Marianne Mikaelsson's contributions to pharmaceutical innovations, particularly in the area of Factor VIII compositions, highlight her role as a significant inventor. Her work continues to pave the way for advancements in medical treatments.